Alicja Ruzik

Alicja Ruzik

Auto-generated profile, based on publicly available information

Alicja Ruzik

Faculty of Medicine, Jan Kochanowski University in Kielce, Kielce, Poland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2026 in American Journal of Case Reports
Verified
Journal Article
Open access
JRJoanna Roskal-Wałek
Joanna Roskal-Wałek
ARAlicja Ruzik
Alicja Ruzik
JBJan Biskup
Jan Biskup
EZEkaterini Zigoura
Ekaterini Zigoura
MBMichał Biskup
Michał Biskup
JGJoanna Gołębiewska
Joanna Gołębiewska
Optical Coherence Tomography Angiography Findings in Post-Traumatic Purtscher Retinopathy: A Case Report - Article abstract #952026

11 March 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
PRPatrycja RęDziniak
Patrycja RęDziniak
MRMonika Rajs
Monika Rajs
PPPatrycja Przebieradło
Patrycja Przebieradło
SŻSandra Żak
Sandra Żak
ARAlicja Ruzik
Alicja Ruzik
STSandra Terpiłowska
Sandra Terpiłowska
Introduction and Purpose:Lithium is a cornerstone of psychopharmacology, with expanding roles beyond psychiatry. This narrative review covers its historical evolution, current applications, and emerging uses in psychiatry, neurology, and general medicine—focusing on bipolar disorder, suicide prevention, neurodegeneration, infections, and pregnancy. The aim is to synthesize mechanistic and clinical data showing how lithium’s actions (GSK-3 inhibition, neurotrophic support, anti-inflammatory effects) enable precise, safe prescribing. Materials and Methods:This narrative synthesis draws from recent systematic reviews, meta-analyses, and key studies on lithium’s efficacy, mechanisms, and novel indications (past decade). PubMed, psychiatry/neurology journals, and public health reports were searched using terms like "lithium bipolar," "lithium suicide," "lithium neurodegeneration," prioritizing robust, clinically relevant sources. Results:Lithium is the gold-standard mood stabilizer (50–67% response rates, ~5-fold suicide risk reduction). Trace lithium in water links to lower suicide/dementia rates. Early data support neuroprotection in MCI/Alzheimer’s, plus roles in cluster headache, infections, and perinatal mood—offset by renal/thyroid/cardiac risks needing monitoring. Conclusions:Lithium excels in bipolar disorder and suicide prevention, with neuroprotective, anti-inflammatory potential. Future focus: low-dose regimens, precision monitoring, digital tools.

15 May 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MKMonika Kowalska
Monika Kowalska
MRMonika Rajs
Monika Rajs
PPPatrycja Przebieradło
Patrycja Przebieradło
SŻSandra Żak
Sandra Żak
ARAlicja Ruzik
Alicja Ruzik
STSandra Terpiłowska
Sandra Terpiłowska
Introduction and Objective: Aesthetic medicine is a rapidly developing field of medicine that significantly improves patients' quality of life in terms of self-esteem and psychological well-being. Modern laser technologies are not only used for rejuvenation, regeneration, or skin pigmentation removal procedures. Laser treatments play a crucial role in the treatment of acne and post-acne changes, allowing not only to reduce disease symptoms but also to minimize the risk of recurrence. The aim of this article is to analyze the course and effectiveness of acne and skin scar therapy through the use of laser technologies, as well as the complexity of potential benefits and possible limitations of their risks. Materials and Methods: This work is based on an analysis of scientific literature concerning the use of laser therapy in the treatment of acne and post-acne scars. A review of existing bibliography was conducted regarding individual types of laser therapy in relation to post-acne scars and acne dermatosis. The course and effectiveness of therapy using lasers were analyzed. Results: Literature analysis showed that modern laser technologies provide effective and relatively safe options for treating acne and post-acne scars. Laser therapy yields moderate but clinically relevant improvements in inflammatory lesions, post-acne scarring, and overall skin texture, with minimal risk when appropriate patient selection and operator expertise are ensured. Conclusions: Laser therapy can substantially enhance outcomes in acne and post-acne scar treatment and contribute to improved patient quality of life. Further studies are needed to establish optimal treatment protocols and to compare the effectiveness of specific laser types across different clinical forms of acne.

25 June 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
KŻKatarzyna Żurek
Katarzyna Żurek
PRPatrycja RęDziniak
Patrycja RęDziniak
MRMonika Rajs
Monika Rajs
PPPatrycja Przebieradło
Patrycja Przebieradło
SŻSandra Żak
Sandra Żak
PWPiotr Wojciechowski
Piotr Wojciechowski
Background. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently defined autoimmune demyelinating disorder of the central nervous system, characterized by antibodies against myelin oligodendrocyte glycoprotein (MOG). Aim. The aim of this review is to systematize the most recent evidence regarding the MOGAD Material and Methods. A systematic literature review was conducted through a comprehensive search of databases (via the PubMed and Google Scholar platforms) Results. MOGAD may occur at any age, most frequently between 20 and 40 years, with variable epidemiological patterns. The clinical spectrum includes optic neuritis, transverse myelitis, acute disseminated encephalomyelitis (ADEM), cortical encephalitis, and brainstem or cerebellar involvement. Age-related phenotypic differences are observed, with ADEM predominating in children and optic neuritis being more common in adults. Biomarkers such as serum MOG-IgG titers, cerebrospinal fluid (CSF) leukocytosis, and oligoclonal band status may reflect disease activity and help predict relapse risk. Persistent seropositivity is associated with a higher likelihood of recurrence, whereas transient positivity correlates with a more favorable course. Acute management primarily includes high-dose corticosteroids, intravenous immunoglobulins (IVIG), and plasma exchange (PLEX). Long-term treatment involves immunomodulatory or immunosuppressive therapies, with oral corticosteroids and IVIG demonstrating the best balance of efficacy and tolerability. Conclusions. MOGAD represents a distinct immunological entity with specific clinical, radiological, and serological features. Ongoing research continues to refine diagnostic criteria, biomarkers, and therapeutic strategies, improving disease recognition and management.

17 June 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
MRMonika Rajs
Monika Rajs
PPPatrycja Przebieradło
Patrycja Przebieradło
PRPatrycja RęDzianiak
Patrycja RęDzianiak
SŻSandra Żak
Sandra Żak
ARAlicja Ruzik
Alicja Ruzik
STSandra Terpiłowska
Sandra Terpiłowska
Prader–Willi syndrome (PWS) is a rare genetic disorder resulting from abnormalities in gene expression. The inability to experience satiety constitutes the major challenge faced by individuals affected by this condition. This lifelong disturbance manifests through numerous complications, including morbid obesity, hypogonadism, infertility, diabetes mellitus, hypercholesterolemia, arterial hypertension, cardiovascular diseases, obstructive sleep apnoea, degenerative joint disease, immobility and even social stigmatization due to excessive body weight. The disease and its secondary complications significantly impair the quality of life and contribute to a reduced life expectancy. Although Prader–Willi syndrome is an uncommon clinical entity, the severity and complexity of its manifestations require continuous and coordinated efforts from physicians and healthcare professionals.

26 June 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
KSKaja Stolarska
Kaja Stolarska
AGAntonina Gaj-Hunter
Antonina Gaj-Hunter
PRPatrycja RęDziniak
Patrycja RęDziniak
ARAlicja Ruzik
Alicja Ruzik
MRMonika Rajs
Monika Rajs
STSandra Terpiłowska
Sandra Terpiłowska
Background: Polycystic Ovary Syndrome (PCOS) affects 5–26% of reproductive-age women, yet current diagnostic frameworks insufficiently distinguish metabolically distinct phenotypes, particularly lean PCOS (BMI ≤25 kg/m²). Objective: This narrative review evaluates lean PCOS as a distinct pathophysiological entity and discusses its neuroendocrine and metabolic features, diagnostic challenges, and weight-stratified classification approaches. Methods: A literature search of PubMed, Google Scholar, and clinical guidelines (2015–2026) was conducted, including meta-analyses and comparative studies of lean and obese PCOS phenotypes. Results: Lean PCOS is characterized by neuroendocrine predominance (elevated LH/FSH ratio, adrenal androgen excess), intrinsic insulin resistance independent of BMI, and altered adipokine signaling reflecting adipose tissue dysfunction. Despite relatively favorable cardiometabolic profiles, patients exhibit subclinical hepatic and vascular risk. Genetic studies confirm distinct metabolic and insulin-signaling pathway involvement. Conclusions: Lean PCOS represents a biologically distinct phenotype requiring weight-stratified diagnostic strategies and phenotype-specific therapeutic approaches, including investigation of incretin-based therapies.